XTRA:MRKPharmaceuticals
Evaluating Merck KGaA (XTRA:MRK) After Sphingolipids Growth Outlook Fuels Fresh Investor Interest
Future Market Insights projects the global sphingolipids market to reach USD 1,145.6 million by 2035, and Merck KGaA (XTRA:MRK) is identified as a key supplier of high purity sphingolipid products and delivery systems.
See our latest analysis for Merck KGaA.
Merck KGaA’s role in the sphingolipids market sits against a backdrop of a €127.8 share price, a 10.41% 90 day share price return, and a 5.36% year to date share price return. At the same time, the 1 year total shareholder return of a...